References
- RoddyEZhangWDohertyMThe changing epidemiology of goutNat Clin Pract Rheumatol20073844344917664951
- SmithEHoyDCrossMThe global burden of gout: estimates from the Global Burden of Disease 2010 studyAnn Rheum Dis20147381470147624590182
- KuoCFGraingeMJMallenCZhangWDohertyMRising burden of gout in the UK but continuing suboptimal management: a nationwide population studyAnn Rheum Dis201574466166724431399
- WheltonAMacdonaldPAZhaoLHuntBGunawardhanaLRenal function in gout: long-term treatment effects of febuxostatJ Clin Rheumatol201117171321169856
- KhannaPPNukiGBardinTTophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: results from a cross-sectional surveyHealth Qual Life Outcomes20121011722999027
- TriesteLPallaIFuscoFThe economic impact of gout: a systematic literature reviewClin Exp Rheumatol2012304 Suppl 73S145S14823072897
- Perez-RuizFMartinez-IndartLCarmonaLHerrero-BeitesAMPijoanJIKrishnanETophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with goutAnn Rheum Dis201473117718223313809
- VincentZLGambleGHouseMPredictors of mortality in people with recent-onset gout: a prospective observational studyJ Rheumatol201744336837327980010
- DesideriGCastaldoGLombardiAIs it time to revise the normal range of serum uric acid levels?Eur Rev Med Pharmacol Sci20141891295130624867507
- TauscheAKJansenTLSchroderHEBornsteinSRAringerMMüller-LadnerUGout–current diagnosis and treatmentDtsch Arztebl Int200910634–3554955519795010
- KiltzUSmolenJBardinTTreat-to-target (T2T) recommendations for goutAnn Rheum Dis201676463263827658678
- RichettePDohertyMPascualE2016 updated EULAR evidence-based recommendations for the management of goutAnn Rheum Dis2017761294227457514
- BriesacherBAAndradeSEFouayziHChanKAComparison of drug adherence rates among patients with seven different medical conditionsPharmacotherapy200828443744318363527
- WHOAdherence to long-term therapies. Evidence for action Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/Accessed April 16, 2018
- HigueraLCarlinCSAndersonSAdherence to disease-modifying therapies for multiple sclerosisJ Manag Care Spec Pharm201622121394140127882830
- MoriskyDEGreenLWLevineDMConcurrent and predictive validity of a self-reported measure of medication adherenceMed Care198624167743945130
- SpectorSLKinsmanRMawhinneyHCompliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trialsJ Allergy Clin Immunol1986771 Pt 165703511127
- TanCTengGGChongKJUtility of the Morisky Medication Adherence Scale in gout: a prospective studyPatient Prefer Adherence2016102449245727980395
- de AchavalSSuarez-AlmazorMEImproving treatment adherence in patients with rheumatologic diseaseJ Musculoskelet Med20102710169147624078770
- McGowanBBennettKSilkeCWhelanBAdherence and persistence to urate-lowering therapies in the Irish settingClin Rheumatol201635371572125409858
- VitolinsMZRandCSRappSRRibislPMSevickMAMeasuring adherence to behavioral and medical interventionsControl Clin Trials2000215 Suppl188S194S11018574
- WuEQPatelPAYuAPDisease-related and all-cause health care costs of elderly patients with goutJ Manag Care Pharm200814216417518331118
- FischerACloutierMGoodfieldJBorrelliRMarvinDDziarmagaAThe direct economic burden of gout in an elderly Canadian populationRheumatol201744195101
- AbhishekAJenkinsWLa-CretteJFernandesGDohertyMLong-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept studyRheumatology (Oxford)201756452953328082620
- HillJBirdHJohnsonSEffect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomized controlled trialAnn Rheum Dis200160986987511502614
- NICEMedicines adherence: involving patients in decisions about prescribed medicines and supporting adherenceClinical guideline CG76 Available from: https://www.nice.org.uk/guidance/cg76/resources/medicines-adherence-involving-patients-in-decisions-about-prescribed-medicines-and-supporting-adherence-pdf-975631782085Accessed April 18, 2018
- Garcia-PerezLEAlvarezMDillaTGil-GuillénVOrozco-BeltránDAdherence to therapies in patients with type 2 diabetesDiabetes Ther20134217519423990497
- Dunbar-JacobJErlenJASchlenkEARyanCMSereikaSMDoswellWMAdherence in chronic diseaseAnnu Rev Nurs Res200018489010918932
- HugtenburgJGTimmersLEldersPJVervloetMvan DijkLDefinitions, variants, and causes of nonadherence with medication: a challenge for tailored interventionsPatient Prefer Adherence2013767568223874088
- NilssonJLAnderssonKBergkvistABjörkmanIBrismarAMoenJRefill adherence to repeat prescriptions of cancer drugs to ambulatory patientsEur J Cancer Care (Engl)200615323523716882118
- VrijensBVinczeGKristantoPUrquhartJBurnierMAdherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing historiesBMJ200833676531114111718480115
- TomaszewskiMWhiteCPatelPHigh rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysisHeart20141001185586124694797
- NHLBIPrevention, Detection, Evaluation, and Treatment of High Blood Pressure Available from: https://www.nhlbi.nih.gov/files/docs/guidelines/jnc7full.pdfAccessed April 18, 2018
- CramerJAA systematic review of adherence with medications for diabetesDiabetes Care20042751218122415111553
- De VeraMAMarcotteGRaiSGaloJSBholeVMedication adherence in gout: a systematic reviewArthritis Care Res (Hoboken)201466101551155924692321
- HarroldLRAndradeSEBriesacherBAAdherence with urate-lowering therapies for the treatment of goutArthritis Res Ther2009112R4619327147
- Zandman-GoddardGAmitalHShamrayevskyNRazRShalevVChodickGRates of adherence and persistence with allopurinol therapy among gout patients in IsraelRheumatology (Oxford)20135261126113123392592
- MantarroSCapogrosso-SansoneATuccoriMAllopurinol adherence among patients with gout: an Italian general practice database studyInt J Clin Pract201569775776525683693
- CorbettEJPentonyPMcGillNWAchieving serum urate targets in gout: an audit in a gout-oriented rheumatology practiceInt J Rheum Dis201720789489728205336
- DehlinMEkstromEHPetzoldMStrömbergUTelgGJacobssonLTFactors associated with initiation and persistence of urate-lowering therapyArthritis Res Ther2017191628095891
- RichettePFlipoRNPatrikosDKCharacteristics and management of gout patients in Europe: data from a large cohort of patientsEur Rev Med Pharmacol Sci201519463063925753881
- ChiaFLPoorly controlled gout: who is doing poorly?Singapore Med J201657841241427549096
- Nasser-GhodsiNHarroldLROvercoming adherence issues and other barriers to optimal care in goutCurr Opin Rheumatol201527213413825633242
- HarroldLRMazorKMVeltenSOckeneISYoodRAPatients and providers view gout differently: a qualitative studyChronic Illn20106426327120675361
- SinghJAFacilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative studyArthritis Res Ther2014162R8224678765
- SpencerKCarrADohertyMPatient and provider barriers to effective management of gout in general practice: a qualitative studyAnn Rheum Dis20127191490149522440822
- SolomonDHAvornJLevinRBrookhartMAUric acid lowering therapy: prescribing patterns in a large cohort of older adultsAnn Rheum Dis200867560961317728328
- KuoCFGraingeMJMallenCZhangWDohertyMEligibility for and prescription of urate-lowering treatment in patients with incident gout in EnglandJAMA2014312242684268625536262
- VaccherSKannangaraDRBaysariMTBarriers to care in gout: from prescriber to patientJ Rheumatol201643114414926568590
- AnnemansLSpaepenEGaskinMGout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005Ann Rheum Dis200867796096617981913
- ReesFHuiMDohertyMOptimizing current treatment of goutNat Rev Rheumatol201410527128324614592
- MikulsTRMacLeanCHOlivieriJQuality of care indicators for gout managementArthritis Rheum200450393794315022337
- MikulsTRFarrarJTBilkerWBFernandesSSaagKGSuboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD)Rheumatology (Oxford)20054481038104215870145
- SpaetgensBPustjensTScheepersLEJMJanssensHJEMvan der LindenSBoonenAKnowledge, illness perceptions and stated clinical practice behaviour in management of gout: a mixed methods study in general practiceClin Rheumatol20163582053206126898982
- GoldfienRDNgMSYipGEffectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot studyBMJ Open201441e003627
- CoburnBWCheethamTCRashidNRationale and design of the randomized evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-UP) StudyContemp Clin Trials20165010611527449546
- ReesFJenkinsWDohertyMPatients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational studyAnn Rheum Dis201372682683022679303
- RobinsonPCSchumacherHRJrA qualitative and quantitative analysis of the characteristics of gout patient education resourcesClin Rheumatol201332677177823322247
- FieldsTRRifaatAYeeAMPilot study of a multidisciplinary gout patient education and monitoring programSemin Arthritis Rheum201746560160827931979
- FernonANguyenABaysariMDayRA User-centred approach to designing an eTool for gout managementStud Health Technol Inform2016227283327440285
- NguyenADBaysariMTKannangaraDRMobile applications to enhance self-management of goutInt J Med Inform201694677427573313
- AungTMyungGFitzGeraldJDTreatment approaches and adherence to urate-lowering therapy for patients with goutPatient Prefer Adherence20171179580028458524